Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-791325 + PegIFN/RBV in HCV Genotype 1
NCT01193361Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beclabuvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Oct 2010; status: completed.
02
Drugs
beclabuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01193361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193361.